These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6987256)

  • 1. Acute effects of saralasin on plasma aldosterone in different pathophysiological conditions.
    Anderson GH; Anderson T; Streeten DH; Schroeder ET
    J Clin Endocrinol Metab; 1980 Mar; 50(3):529-36. PubMed ID: 6987256
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
    J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
    [No Abstract]   [Full Text] [Related]  

  • 4. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
    Fagard R; Lijnen P; Amery A; Reybrouck T
    Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
    Higuma K; Fujishima S; Shionoiri H; Tochikubo O; Uneda S; Fujiki Y; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for an angiotensinogenic mechanism of the hypertension of Cushing's syndrome.
    Dalakos TG; Elias AN; Anderson GH; Streeten DH; Schroeder ET
    J Clin Endocrinol Metab; 1978 Jan; 46(1):114-8. PubMed ID: 752014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II and sodium as determinants of the agonistic--antagonistic balance of saralasin's actions.
    Fagard R; Amery A; Lijnen P
    Clin Sci (Lond); 1981 Apr; 60(4):377-85. PubMed ID: 7018793
    [No Abstract]   [Full Text] [Related]  

  • 11. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
    Klaus D; Witzgall H; Zehner J; Dürr H; Lange H
    Dtsch Med Wochenschr; 1976 Sep; 101(37):1357-9. PubMed ID: 954592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the biological effects of two angiotensin II analogues in hypertensive patients with sodium depletion.
    Hata T; Ogihara T; Mikami H; Nakamaru M; Maruyama A; Mandai T; Kumahara Y
    Life Sci; 1978 Jun; 22(21):1955-62. PubMed ID: 672437
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of sar1 ala8 angiotensin II (saralasin) on plasma aldosterone in hypertensive patients.
    Donker AJ; van Hoogdalem P; Pratt JJ; Leenen FH
    Acta Med Scand; 1979; 205(3):207-12. PubMed ID: 425848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
    Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
    Mimran A; Shaldon S; Barjon P; Mion C
    Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
    Nigawara K; Yagihashi Y; Kogawa T; Kawamata A; Yamaya K; Sugawara S; Tulachan Y; Funyu T; Eba H; Kido K; Tanaka T; Morita S; Fukushi M; Furusawa M; Terayama Y; Hirayama N
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
    Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
    Schroeder ET; Anderson GH; Goldman SH; Streeten DH
    Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II and not sodium status is the major determinant of the agonistic/antagonistic balance of saralasin's actions.
    Fagard R; Amery A; Lijnen P
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():75s-78s. PubMed ID: 7004740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal adrenal and vascular responses to angiotensin II and an angiotensin antagonist in acromegaly.
    Moore TJ; Thein-Wai W; Dluhy RG; Dawson-Hughes BF; Hollenberg NK; Williams GH
    J Clin Endocrinol Metab; 1980 Aug; 51(2):215-22. PubMed ID: 6995474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.